Sai Life Sciences Limited (NSE:SAILIFE)

India · Delayed Price · Currency is INR

985.85

-26.50 (-2.62%)

At close: Mar 27, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Contract Research, Development and Manufacturing Services (CRDMO)	16.95B	14.65B	12.17B	8.70B	7.60B
Contract Research, Development and Manufacturing Services (CRDMO) Growth	15.66%	20.38%	39.97%	14.44%	-
Total	16.95B	14.65B	12.17B	8.70B	7.60B
Total Growth	15.66%	20.38%	39.97%	14.44%	-

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
India	210.31M	178.68M	207.57M	681.49M	426.76M
India Growth	17.70%	-13.92%	-69.54%	59.69%	-
outside India	16.39B	14.39B	11.76B	8.01B	7.16B
outside India Growth	13.96%	22.31%	46.85%	11.86%	-
Total	16.60B	14.56B	11.97B	8.69B	7.59B
Total Growth	14.00%	21.68%	37.72%	14.55%	-

Source: S&P Global Market Intelligence.